We are live on ! Find out more
SYRE icon

Spyre Therapeutics

Name Holding Trade Value Shares
Change
Change in
Stake
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$2.81M
SCM
2
Sio Capital Management
New York
$2.46M
SCM
3
Suvretta Capital Management
New York
$2.14M
NCM
4
Nantahala Capital Management
Connecticut
$1.95M -$82.3K -6,661 -4%
RSCM
5
Rock Springs Capital Management
Maryland
$1.8M +$169K +13,675 +11%
BBA
6
Baker Bros. Advisors
New York
$1.79M
PAMS
7
Pictet Asset Management (Switzerland)
Switzerland
$1.34M -$1.16M -93,903 -48%
GPP
8
Great Point Partners
Connecticut
$1.31M
Vanguard Group
9
Vanguard Group
Pennsylvania
$993K -$29.9K -2,424 -3%
O
10
OrbiMed
New York
$945K
ACM
11
Aisling Capital Management
New York
$890K
Adage Capital Partners
12
Adage Capital Partners
Massachusetts
$789K
BlackRock
13
BlackRock
New York
$542K -$18.2K -1,477 -3%
GTC
14
Ghost Tree Capital
New York
$526K +$37.1K +3,000 +8%
Goldman Sachs
15
Goldman Sachs
New York
$482K -$134K -10,864 -23%
SB
16
Samsara BioCapital
California
$465K
Millennium Management
17
Millennium Management
New York
$429K +$145K +11,710 +56%
Acadian Asset Management
18
Acadian Asset Management
Massachusetts
$245K +$27.3K +2,207 +13%
Two Sigma Advisers
19
Two Sigma Advisers
New York
$216K +$88.1K +7,128 +77%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$207K
Assenagon Asset Management
21
Assenagon Asset Management
Luxembourg
$168K -$160K -12,975 -50%
Renaissance Technologies
22
Renaissance Technologies
New York
$131K -$164K -13,306 -57%
UOTTAIMCU
23
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$129K
A
24
Abingworth
United Kingdom
$127K
Morgan Stanley
25
Morgan Stanley
New York
$88K -$62K -5,023 -43%